首页> 美国卫生研究院文献>Journal of Clinical Medicine >The Rise of Mitochondria in Peripheral Arterial Disease Physiopathology: Experimental and Clinical Data
【2h】

The Rise of Mitochondria in Peripheral Arterial Disease Physiopathology: Experimental and Clinical Data

机译:线粒体在周围动脉疾病生理病理学中的兴起:实验和临床数据

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Peripheral arterial disease (PAD) is a frequent and serious condition, potentially life-threatening and leading to lower-limb amputation. Its pathophysiology is generally related to ischemia-reperfusion cycles, secondary to reduction or interruption of the arterial blood flow followed by reperfusion episodes that are necessary but also—per se—deleterious. Skeletal muscles alterations significantly participate in PAD injuries, and interestingly, muscle mitochondrial dysfunctions have been demonstrated to be key events and to have a prognosis value. Decreased oxidative capacity due to mitochondrial respiratory chain impairment is associated with increased release of reactive oxygen species and reduction of calcium retention capacity leading thus to enhanced apoptosis. Therefore, targeting mitochondria might be a promising therapeutic approach in PAD.
机译:周围动脉疾病(PAD)是一种常见且严重的疾病,可能危及生命并导致下肢截肢。其病理生理通常与局部缺血-再灌注循环有关,继之以动脉血流减少或中断,继之以必要的但本身也是有害的再灌注发作。骨骼肌改变明显参与了PAD损伤,有趣的是,线粒体功能障碍是关键事件,具有预后价值。线粒体呼吸链损伤引起的氧化能力降低与活性氧的释放增加和钙保留能力降低有关,从而导致细胞凋亡增加。因此,靶向线粒体可能是PAD中一种有希望的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号